Clinical trial Recruiting at 1 site Interventional Ages 5 to 18

Using high-dose vitamin D to treat overactive bladder in children

Official title: Efficacy, Neural Repair Mechanism, and Health Economics of a Multimodal Treat-to-Target Strategy Incorporating Vitamin D for Pediatric Overactive Bladder-Wet: A Randomized Controlled Trial

Run by Children's Hospital of Chongqing Medical University · NCT06201013 · Data updated 2026-11-12

This study is testing if giving high-dose vitamin D along with regular therapy can help children with wet overactive bladder feel better compared to just therapy or therapy with a medication.

Quick facts

Study typeInterventional
Ages5 Years to 18 Years
SexAll
Enrollment180 (estimated)
SponsorChildren's Hospital of Chongqing Medical University
Academic / other
Locations1 site (Chongqing, Chongqing Municipality)
StatusRecruiting
StartedApril 20, 2026
Main results expectedSeptember 15, 2026
Study endsApril 15, 2027
Registry record updatedApril 17, 2026
Trial IDNCT06201013 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 5 and older diagnosed with wet OAB and having low serum vitamin D levels.

Probably not a fit

Patients with urinary malformations, serious diseases, or neurological disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the efficacy and safety of high-dose vitamin D (2400iu daily) combined with standard behavioral therapy in treating children with wet overactive bladder (OAB). It compares this approach to standard behavioral therapy alone and to a combination of behavioral therapy with solifenacin medication. The study aims to assess improvements in urinary incontinence frequency and lower urinary tract symptoms, while also exploring the relationship between vitamin D levels and these symptoms. Participants will be randomized into three groups to evaluate the effectiveness and safety of the interventions.

Why it matters

Potential benefit: If successful, this study could provide a new treatment option that improves urinary incontinence and quality of life for children with wet OAB.

How similar studies have gone: While the combination of vitamin D with behavioral therapy is a novel approach, previous studies have shown potential benefits of vitamin D in various conditions, suggesting a promising avenue for exploration.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children older than or equal to 5 years of age with a diagnosis of wet OAB (the diagnosis followed the latest guidelines of ICCS) attending the outpatient clinic of the Department of Urology of the Affiliated Children's Hospital of Chongqing Medical University,
* children with serum vitamin D levels below 35 ng/ml as indicated by the tests conducted by the hospital
* children whose guardians have given their informed consent, are able to ensure compliance and have signed a paper-based informed consent form.

Exclusion Criteria:

* Those with urinary malformations or serious diseases (e.g., hypospadias, cryptorchidism, posterior urethral valvulae, vesicoureteral reflux, neurogenic bladder, urinary tumors, urinary stones, bladder and urethral injuries, etc.)
* Those with neurological disorders (e.g., epilepsy, spinal cord injuries, spinal dysplasia, spinal embolism syndrome, multiple sclerosis, and autism spectrum disorders, etc.)
* People with serious heart disease, abnormal liver and kidney function, lung disease, bone deformity, serious digestive tract disease, genetic metabolic disease
* People with history of gastrointestinal surgery and urological surgery
* People with dry stools and long-term constipation
* People who are taking anticonvulsant and antiepileptic drugs, hormones, and anti-tuberculosis drugs
* People with history of hypercalcemia, hyperphosphatemia with renal rickets
* People who have had unexplained hematuria and hematuria with renal rickets within the last year
* People who have been suffering from severe heart disease or chronic diabetes.
* participation in other clinical studies at the time of consultation or during the follow-up period of other clinical studies
* unwillingness to participate in this study

Where it's running

  • Children's Hospital of Chongqing Medical University
    Chongqing, Chongqing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.